文献速递糖尿病

DNA甲基化吸烟评分与胰岛自身免疫及1型糖尿病风险

DNA Methylation Smoking Scores and Risk of Islet Autoimmunity and Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2025-01-01

基于青少年糖尿病自身免疫研究队列的205例胰岛自身免疫病例和206例对照(其中1型糖尿病病例和对照各87例和88例),采用DNA甲基化吸烟评分评估宫内吸烟暴露与胰岛自身免疫及1型糖尿病风险的关联。多变量模型显示母亲孕期自报吸烟和较高DNA甲基化吸烟评分均与较低的胰岛自身免疫和1型糖尿病风险相关。

要点

  • 母亲孕期自报吸烟与胰岛自身免疫风险降低相关(OR 0.24;95%CI 0.10-0.54)。
  • Rauschert和McCartney DNA甲基化评分与两种结局呈一致负相关(每标准差增加OR 0.65-0.83)。
  • 研究支持宫内吸烟暴露与胰岛自身免疫及1型糖尿病风险降低相关。

核心结论

  • 研究支持现有文献提示宫内吸烟暴露与胰岛自身免疫和1型糖尿病风险降低相关。
  • 需进一步研究以揭示 underlying 机制。

研究设计与样本

  • 采用青少年糖尿病自身免疫研究队列的纵向数据,纳入205例胰岛自身免疫病例和206例对照(其中1型糖尿病病例和对照分别为87例和88例),按年龄、种族/民族和样本可用性匹配。
  • DNA甲基化谱来自脐带血或外周血,使用Infinium Human Methylation 450K或EPIC BeadChip芯片检测。
  • 在每个时间点计算三种已发表的DNA甲基化吸烟评分;通过纵向DNA甲基化评分的混合效应模型推导参与者特异性截距以估计宫内吸烟暴露。
  • 截距与脐带血评分强相关(r=0.85-0.95;n=179),表明其可作为宫内吸烟暴露的替代指标。
  • 采用逻辑回归评估与胰岛自身免疫/1型糖尿病的关联,调整HLA-DR3/4、一级亲属状态和性别。

主要发现

  • 多变量模型显示,母亲孕期自报吸烟与胰岛自身免疫风险降低相关(OR 0.24;95%CI 0.10-0.54)。
  • Rauschert和McCartney DNA甲基化评分与胰岛自身免疫和1型糖尿病两种结局均呈一致负相关(每标准差增加OR 0.65-0.83)。

局限性

  • 需进一步研究以揭示 underlying 机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Multiple studies have reported an inverse association between self-reported smoking during pregnancy and offspring type 1 diabetes (T1D) risk. We investigated the association between DNA methylation (DNAm) smoke exposure scores, parental self-reported smoking, and islet autoimmunity (IA) and T1D risk in children at high risk of T1D. RESEARCH DESIGN AND METHODS: We used longitudinal data from the Diabetes Autoimmunity Study in the Young cohort, including 205 IA case and 206 control participants (87 and 88 were T1D case and control participants, respectively), matched by age, race/ethnicity, and sample availability. DNAm profiles were obtained from cord or peripheral blood using the Infinium Human Methylation 450K or EPIC BeadChip. Three published DNAm smoking scores were calculated at every time point. To estimate in utero smoke exposure, participant-specific intercepts were derived from mixed-effects models of longitudinal DNAm scores. These intercepts strongly correlated with cord blood scores (r = 0.85-0.95; n = 179), indicating their utility as proxies for in utero smoke exposure. Associations with IA/T1D were evaluated using logistic regression, adjusting for HLA-DR3/4, first-degree relative status, and sex. RESULTS: Multivariable models showed both maternally reported smoking during pregnancy and higher DNAm smoking scores to be associated with lower risk of IA and T1D. Maternal smoking showed a strong inverse association with IA (odds ratio [OR] 0.24; 95% CI 0.10-0.54). Rauschert and McCartney DNAm scores showed consistent inverse associations with both outcomes (OR 0.65-0.83 for SD increase). CONCLUSIONS: Our study supports existing literature indicating in utero smoke exposure is associated with reduced IA and T1D risk. Further research is essential to uncover the underlying mechanisms.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Vanderlinden LA, Wong E, Johnson RK, et al. DNA Methylation Smoking Scores and Risk of Islet Autoimmunity and Type 1 Diabetes. Diabetes Care. 2025. PMID: 40712097. doi:10.2337/dc25-0330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。